Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 1, 1999, Pages 90-98

  Postle, Anthony D ^a   Mander, Ann ^b   Reid, Kenneth B M ^b   Wang, Jiu Yao ^b   Wright, Sarah M ^b   Moustaki, Maria ^b   Warner, John O ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

GLYCOPROTEIN; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; PROTEOLIPID; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ARTICLE; BACTERIAL INFECTION; CHEMISTRY; CHILD; CYSTIC FIBROSIS; GRAM NEGATIVE INFECTION; HUMAN; LUNG DISEASE; LUNG LAVAGE; MASS SPECTROMETRY; METABOLISM; MICROBIOLOGY;

BACTERIAL INFECTIONS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CYSTIC FIBROSIS; GLYCOPROTEINS; HUMANS; LUNG DISEASES; MASS SPECTROMETRY; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPIDS; PROTEOLIPIDS; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS;

EID: 0032615014     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.1.3253     Document Type: Article

References (32)

1. Hata, J. S., and R. B. Fick. 1987. Isolation and partial characterization of epithelial-cell membrane proteins binding Pseudomonas aeruginosa (PSA). Clin. Res. 35:901 A. (Abstr.)
2. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
3. Enhorning, G., and B. A. Holm. 1993. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J. Appl. Physiol. 74:2922 2927.
4. Kakuta, Y., H. Sasaki, and T. Takishima. 1991. Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. Respir. Physiol. 47:225-231.
5. Wilsher, M. L., D. A. Hughes, and P. L. Haslam. 1988. Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes. Thorax 43:353-359.
6. Allen, J. N., S. A. Moore, A. L. Pope-Harman, C. B. Marsh, and M. D. Wewers. 1995. Immunosuppressive properties of surfactant and plasma on alveolar macrophages. J. Lab. Clin. Med. 125:356-369.
7. Gilljam, H., B. Strandvik, A. Ellin, and L. G. Witman. 1986. Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis. Scand. J. Clin. Lab. Invest. 46:511-518.
8. Girod, S., C. Galabert, A. Lecuire, J. M. Zahm, and E. Puchelle. 1992. Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive airways disease. Pediatr. Pulmonol. 13:22-27.
9. Griese, M., P. Birrer, and A. Demirsoy. 1997. Pulmonary surfactant in cystic fibrosis. Eur. Respir. J. 10:1983-1988.
10. Hull, J., M. South, P. Phelan, and K. Grimwood. 1997. Surfactant composition in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 156:161-165.
11. Holm, B. A., Z. D. Wang, E. A. Egan and R. H. Notter. 1996. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity. Pediatr. Res. 39:805-811.
12. Han, X., and R. W. Gross. 1994. Electrospray ionisation mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc. Natl. Acad. Sci. USA 91:10635-10639.
13. Brügger, B., G. Erben, R. Sandhoff, F. T. Wieland, and W. D. Lehmann. 1997. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 94:2339-2344.
14. Raine, J., and J. O. Warner. 1991. Fibreoptic bronchoscopy without general anaesthetic. Arch. Dis. Child. 66:481-484.
15. Barbato, A., M. Magarotto, M. Crivellaro, A. Novello, Jr., A. Cracco, J. de Blic, P. Scheinmann, J. O. Warner, and M. Zach. 1997. Use of the paediatric bronchoscope, flexible and rigid, in 51 European centres. Eur. Respir. J. 10:1761-1766.
16. Bartlett, G. R. 1959. Phosphorous assay in column chromatography. J. Biol. Chem. 234:466-468.
17. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
18. Postle, A. D. 1987. Method for the sensitive analysis of individual molecular species of phosphatidylcholine by high-performance liquid chromatography using post-column fluorescence detection. J. Chromatogr. 419:214-251.
19. Miyamura, K., R. Malhotra, H. J. Hoppe, K. B. M. Reid, P. J. R. Phizackerly, P. Macpherson, and A. L. Bernal. 1994. Surfactant protein A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in fetal membranes. Biochim. Biophys. Acta 1210:303-307.
20. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
21. Hunt, A. N., F. J. Kelly, and A. D. Postle. 1991. Developmental variation in whole human lung phosphatidylcholine molecular species: a comparison with guinea pig and rat. Early Hum. Dev. 25:157-171.
22. Hayashi, H., H. Adachi, K. Kataoka, H. Sato, and T. Akino. 1990. Molecular species profiles of acidic phospholipids in lung fractions of adult and perinatal rabbits. Biochim. Biophys. Acta 1042:126-131.
23. Baughman, R. P., R. J. Sternberg, W. Hull, J. A. Buchsbaum, and J. Whitsett. 1993. Decreased surfactant protein A in patients with bacterial pneumonia. Am. Rev. Respir. Dis. 147:653-657.
24. McIntosh, J. C., A. H. Swyers, J. H. Fisher, and J. R. Wright. 1996. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 15:509-519.
25. Kronborg, G. 1995. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. APMIS 103 (S50):1-30.
26. Ashton, M. R., A. D. Postle, M. A. Hall, S. L. Smith, F. J. Kelly, and I. C. S. Normand. 1992. Phosphatidylcholine composition of endotracheal tube aspirates of neonates and subsequent respiratory disease. Arch. Dis. Child. 67:378-382.
27. Han, X., R. A. Gubitosi-Klug, B. J. Collins, and R. W. Gross. 1996. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionisation mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. Biochemistry 35:5822-5832.
28. Chao, W., R. G. Spragg, and R. M. Smith. 1995. Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. J. Clin. Invest. 96:2654-2660.
29. Kremlev, S. G., T. M. Umstead, and D. S. Phelps. 1994. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am. J. Physiol. 267:L357-L364.
30. Griese, M., P. Bufler, J. Teller, and D. Reinhardt. 1997. Nebulization of a bovine surfactant in cystic fibrosis: a pilot study. Eur. Respir. J. 10:1989-1994.
31. mIHGU/mlHGU mice. Thorax 52:723-730.
32. Le Vine, A. M., M. D. Bruno, K. M. Huelsman, G. F. Ross, J. A. Whitsett, and T. R. Korfhagen. 1997. Surfactant protein A-deficient mice are susceptible to Group B Streptococcal infection. J. Immunol. 158:4336-4350.